LPL Financial’s Zosano Pharma Corporation ZSAN Stock Holding History

LPL Financial’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-857	Closed	-$7K	–	4584
2022 Q1	$7K	Sell	857 -1,263	-60%	-$13.9K	﹤0.01%	4163
2021 Q4	$35K	Buy	2,120 +443	+26%	+$9.35K	﹤0.01%	4260
2021 Q3	$42K	Buy	1,677 +820	+96%	+$21.3K	﹤0.01%	4243
2021 Q2	$29K	Hold	857	–	–	﹤0.01%	4180
2021 Q1	$37K	Hold	857	–	–	﹤0.01%	4016
2020 Q4	$16K	Hold	857	–	–	﹤0.01%	3788
2020 Q3	$49K	Buy	857 +171	+25%	+$7.96K	﹤0.01%	3440
2020 Q2	$21K	Hold	686	–	–	﹤0.01%	3413
2020 Q1	$13K	Buy	+686	New	+$23K	﹤0.01%	3169

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

LPL Financial's ZSAN Position: Q2 2022 in Review

LPL Financial sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 857 shares — an estimated $7K sold.

LPL Financial first reported a position in ZSAN in Q1 2020 and held it in 9 quarters. The position peaked at $49K in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

LPL Financial reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
LPL Financial sold 857 Zosano Pharma Corporation shares in Q2 2022, an estimated $7K.
LPL Financial first reported a position in Zosano Pharma Corporation in Q1 2020 and held it in 9 quarters.
LPL Financial's Zosano Pharma Corporation position peaked at $49K in Q3 2020.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.